CTBC Financial Holding Announces Taiwan Life's Approval to Invest in Advent Mid-Market Private Equity-A SCSp

1. Name and nature of the subject matter (if preferred shares, specify issuance terms such as dividend rate): Advent Mid-Market Private Equity-A SCSp; a private equity fund

2. Date of occurrence: 115/06/24

3. Number of units, price per unit, and total transaction amount: Not applicable, not applicable, not exceeding USD 20,000,000

4. Counterparty and its relationship with the company (if the counterparty is an individual and not a related party, name disclosure may be omitted): Advent Mid-Market Private Equity GP S.a r.l., unrelated party

5. If the counterparty is a related party, disclose the reason for selecting such party, the previous transferor, the relationship among the previous transferor, the company, and the counterparty, the previous transfer date, and the transfer amount: Not applicable

6. If the ownership of the subject matter was held by a related party of the company within the past five years, disclose the date, price, and relationship with the company at the time of acquisition and disposal: Not applicable

7. Matters related to the disposal of receivables (including types of collateral attached to disposed receivables; if receivables from related parties are disposed, disclose the name and book value): Not applicable

8. Gain (or loss) from disposal (not applicable for acquisition of securities) (if deferred, provide a table showing recognition): Not applicable

9. Delivery or payment terms (including payment period and amount), contractual restrictions, and other important agreements: Delivery or payment terms (including payment period and amount): as stipulated in the contract Contractual restrictions and other important agreements: as stipulated in the contract

10. Method of determining the transaction, reference basis for price determination, and decision-making unit: Method of determining the transaction, reference basis for price determination: as stipulated in the contract Decision-making unit: according to the company's approval authority

11. Net asset value per share of the securities-issuing company: Not applicable

12. Difference between private placement reference price and per-share transaction price exceeding 20%: Not applicable

13. Cumulative holdings of the securities involved in this transaction (including this transaction) as of now, in terms of quantity, amount, ownership percentage, and restricted rights (e.g., pledge status): Parent company: no holdings Company: not applicable, not exceeding USD 20,000,000, approximately 0.67%, none Subsidiaries: no holdings

14. Proportion of private placement securities investment (including this transaction) to total assets and equity attributable to owners of the parent in the company's latest financial statements, and the amount of working capital: 3% of total assets, 31% of equity attributable to owners of the parent, working capital: not applicable

15. Manager and brokerage fees: Not applicable

16. Specific purpose or use of the acquisition or disposal: For life insurance fund deployment in accordance with insurance regulations

17. Dissenting opinions from directors regarding this transaction: Not applicable

18. Whether this transaction is a related-party transaction: No

19. Date of board approval: Not applicable, not within the board's approval authority

20. Date of auditor's approval or audit committee consent: Not applicable, not within the board's approval authority

21. Whether the accountant issued an unreasonable opinion on this transaction: No

22. Name of accounting firm: Ching Tien CPA Firm

23. Name of accountant: Hsu Ming-Hsiung

24. Accountant's license number: Taipei City CPA License No. 3723

25. Other disclosures: None